March 2020

18

Mar

Coronavirus Update from Biofortuna

By admin.bio No comments yet

In light of the current situation with COVID-19, we would like to take this opportunity to assure you that plans have been put into place to ensure business continuity at Biofortuna.

Biofortuna is a contract development and manufacturing organisation providing genomic services, custom development and manufacturing support.

Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 17025 accreditation, ISO 13485 certification and FDA registration, we have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.

Footer Menu

Latest news and blogs

<img width="150" height="150" src="https://www.biofortuna.com/wp-content/uploads/2022/08/outosurce-blog-150x150.jpg" class="attachment-boc_thumb size-boc_thumb wp-post-image" alt="" title="Ten reasons to outsource assay manufacture" loading="lazy" />

Ten reasons to outsource assay manufacture

24th August 2022

<img width="150" height="150" src="https://www.biofortuna.com/wp-content/uploads/2022/08/air-150x150.png" class="attachment-boc_thumb size-boc_thumb wp-post-image" alt="" title="Lyophilising or Air Drying. Which is better for my assay?" loading="lazy" />

Lyophilising or Air Drying. Which is better for my assay?

19th August 2022

<img width="150" height="150" src="https://www.biofortuna.com/wp-content/uploads/2022/08/assay-stablisation-blog-150x150.jpg" class="attachment-boc_thumb size-boc_thumb wp-post-image" alt="" title="Re-defining the limits of single batch assay stabilisation" loading="lazy" />

Re-defining the limits of single batch assay stabilisation

17th August 2022

Contact Info

+44 151 334 0182

info@biofortuna.com

Biofortuna Limited, 2 Tenth Avenue, Deeside Industrial Park, Deeside. CH5 2UA

Biofortuna Limited © 2022